drugset / Trial / NCT00025220
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have recurrent or persistent cancer of the uterus. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor.
Timeline
- Start
- 2001-09
- Primary completion
- 2003-04
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | Oral |